Activity of a lipid synthesis inhibitor (spiromesifen) in Culiseta longiareolata (Diptera: Culicidae)

• Published in: Asian Pacific Journal of Tropical Biomedicine
• Main Authors: Hayette Bouabida, Fouzia Tine-djebbar, Samir Tine, Noureddine Soltani
• Format: Article in Journal/Newspaper
• Language: English
• Published: Wolters Kluwer Medknow Publications 2017
• Subjects: Arctic medicine. Tropical medicine; RC955-962; Biology (General); QH301-705.5; Aitken; Arctic
• Online Access: https://doi.org/10.1016/j.apjtb.2017.10.015; https://doaj.org/article/fda520417bdf46fc8756c6022cc21c5d

Objective: To evaluate the activity of spiromesifen against the most abundant and investigated mosquito species, Culiseta longiareolata Aitken, 1954 (Diptera, Culicidae). Methods: Culiseta longiareolata larvae were collected from untreated areas located at Tébessa (Northeast Algeria). A commercial formulation of spiromesifen (Oberon® 240 SC) was tested at different concentrations ranging between 238 and 1428 μg/L on newly molted fourth-instar larvae under standard laboratory conditions according to Word Health Organization recommendations. The effects were examined on the mortality, the morphometric measurements, two biomarkers (catalase and malondialdehyde), and the biochemical composition of larvae, respectively. Results: The compound exhibited insecticidal activity. Moreover, it disturbed growth and several morphological aberrations were observed. It also affected body volume, biomarkers and contents of carbohydrates, lipids and proteins. A marked effect on lipids and malondialdehyde was noted, confirming its primary mode of action on lipid synthesis. Conclusions: Spiromesifen appears less potent than other insecticides tested such as the insect growth disruptors. Keywords: Culiseta longiareolata, Spiromesifen, Toxicity, Biochemical composition, Biomarkers